Industry-Specific Risks & Challenges for Law Firms
Representing clients in DEA-related litigation or regulatory defense carries unique pressures. Cases often involve years of records, internal audits, and distribution patterns that influence the government’s narrative long before counsel enters the discussion. Law firms must move fast, translate operational language into a legal context, and anticipate agency expectations from day one.
Key risks for law firms handling controlled substance cases include:
- DEA audits and investigations: Regulatory inspections can begin without warning. Audit posture within the first few days can determine the trajectory of the entire matter.
- Recordkeeping gaps: Missing or inconsistent documentation can turn into evidence of negligence or mismanagement. Case outcomes often hinge on what appears in those files.
- Diversion exposure: Accusations of drug diversion within a healthcare network or distribution channel can escalate into criminal exposure and reputational damage.
- Civil fines and penalties: Penalties can expand rapidly under the Controlled Substances Act. Counsel must show a clear story of compliance to prevent enforcement escalation.
